Despite the featherlight consistency, this antioxidant serum is chock full of moisturizing and brightening heavyweights
Secretion of GLP-1 but not GIP is potently stimulated by luminal D-Allulose (D-Psicose) in rats
Because they are small molecules, they can penetrate the hair deeply to repair internal damage and increase diameter
Key Takeaways Triple agonist mechanism: Retatrutide is the first medication to activate GIP, GLP-1, and glucagon receptors simultaneously GLP-1 component reduces appetite and slows gastric emptying, the core appetite suppression pathway GIP component improves insulin sensitivity and promotes favorable fat distribution Glucagon component increases energy expenditure through thermogenesis and promotes fat breakdown Weight loss: Phase 2 trials showed up to 24.2% weight loss at 48 weeks, compared to tirzepatide (~22%) and semaglutide (~15%) Investigational status: Not FDA-approved
The combination effectively restored glucose and lipid profiles, reduced oxidative stress, suppressed neuroinflammation, modulated amyloidogenic and apoptotic pathways, and enhanced neurotrophic and insulin signaling, offering comprehensive neuroprotection
